Skip to main content

MoneyWorks4Me

Nectar Lifesciences informs about certificate

05 Oct 2018 Evaluate

Pursuant to Regulation 40(10)of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Nectar Lifesciences has informed about a copy of the certificate, received from a Company Secretary in Practice as required under Regulation 40(9) of said Regulations, for the half year ended September 30, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..